São Paulo call to action for the prevention and control of high blood pressure: 2020

Norm R C Campbell¹, Aletta E Schutte², Cherian V Varghese³, Pedro Ordunez⁴, Xin-Hua Zhang⁵, Taskeen Khan³, James E Sharman⁶, Paul K Whelton⁷, Gianfranco Parati^{8

9}, Michael A Weber¹⁰, Marcelo Orías^{11

12}, Marc G Jaffe^{13

14}, Andrew E Moran¹⁵, Frida Liane Plavnik^{16

17

18}, Venkata S Ram^{19

20

21

22}, Michael Brainin²³, Mayowa O Owolabi²⁴, Augstin J Ramirez²⁵, Eduardo Barbosa²⁶, Luiz Aparecido Bortolotto^{27

18}, Daniel T Lackland²⁸

Affiliations

¹ Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada.
² MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
³ Department of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland.
⁴ Department of Non-Communicable and Mental Health, Pan American Health Organization, Washington, DC, USA.
⁵ Beijing Hypertension League Institute, Beijing, China.
⁶ Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
⁷ Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA.
⁸ Department of Medicine and Surgery, University of Milano-Bicocca & Istituto Auxologico Italiano, IRCCS, Milan, Italy.
⁹ Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
¹⁰ Division of Cardiovascular Medicine, Downstate Medical Center, State University of New York, Brooklyn, NY, USA.
¹¹ Department of Nephrology, Sanatorio Allende, Córdoba, Argentina.
¹² Universidad Nacional de Córdoba, Córdoba, Argentina.
¹³ Resolve to Save Lives, An Initiative of Vital Strategies, New York, NY, USA.
¹⁴ Kaiser Permanente Northern California, South San Francisco, CA, USA.
¹⁵ Global Hypertension Control, Resolve to Save Lives, An initiative of Vital Strategies, New York, NY, USA.
¹⁶ Hypertension Group, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
¹⁷ Heart Institute (InCor), São Paulo, Brazil.
¹⁸ Brazilian Society of Hypertension, São Paulo, Brazil.
¹⁹ University of Texas Southwestern Medical School, Dallas, TX, USA.
²⁰ Apollo Medical College and Hospitals, Hyderabad, India.
²¹ Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
²² World Hypertension League, South Asia Regional Office, Hyderabad, India.
²³ Danube University Krems, Krems, Austria.
²⁴ African Research Universities Center of Excellence for Non-communicable Diseases, University of Ibadan, Ibadan, Nigeria.
²⁵ Arterial Hypertension an Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina.
²⁶ Latin American Society of Hypertension, Artery Latam, Porto Alegre, Brazil.
²⁷ Director of Hypertension Unit, Hospital das Clínicas FMUSP- SP, Heart Institute (InCor), São Paulo, Brazil.
²⁸ Division of Translational Neurosciences and Population Studies, Medical University of South Carolina, Charleston, SC, USA.

PMID: 31769155
PMCID: PMC8030388
DOI: 10.1111/jch.13741

São Paulo call to action for the prevention and control of high blood pressure: 2020

Norm R C Campbell et al. J Clin Hypertens (Greenwich). 2019 Dec.

. 2019 Dec;21(12):1744-1752.

doi: 10.1111/jch.13741. Epub 2019 Nov 25.

Authors

Affiliations

¹ Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada.
² MRC Unit for Hypertension and Cardiovascular Disease, Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
³ Department of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland.
⁴ Department of Non-Communicable and Mental Health, Pan American Health Organization, Washington, DC, USA.
⁵ Beijing Hypertension League Institute, Beijing, China.
⁶ Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
⁷ Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA.
⁸ Department of Medicine and Surgery, University of Milano-Bicocca & Istituto Auxologico Italiano, IRCCS, Milan, Italy.
⁹ Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
¹⁰ Division of Cardiovascular Medicine, Downstate Medical Center, State University of New York, Brooklyn, NY, USA.
¹¹ Department of Nephrology, Sanatorio Allende, Córdoba, Argentina.
¹² Universidad Nacional de Córdoba, Córdoba, Argentina.
¹³ Resolve to Save Lives, An Initiative of Vital Strategies, New York, NY, USA.
¹⁴ Kaiser Permanente Northern California, South San Francisco, CA, USA.
¹⁵ Global Hypertension Control, Resolve to Save Lives, An initiative of Vital Strategies, New York, NY, USA.
¹⁶ Hypertension Group, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
¹⁷ Heart Institute (InCor), São Paulo, Brazil.
¹⁸ Brazilian Society of Hypertension, São Paulo, Brazil.
¹⁹ University of Texas Southwestern Medical School, Dallas, TX, USA.
²⁰ Apollo Medical College and Hospitals, Hyderabad, India.
²¹ Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
²² World Hypertension League, South Asia Regional Office, Hyderabad, India.
²³ Danube University Krems, Krems, Austria.
²⁴ African Research Universities Center of Excellence for Non-communicable Diseases, University of Ibadan, Ibadan, Nigeria.
²⁵ Arterial Hypertension an Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina.
²⁶ Latin American Society of Hypertension, Artery Latam, Porto Alegre, Brazil.
²⁷ Director of Hypertension Unit, Hospital das Clínicas FMUSP- SP, Heart Institute (InCor), São Paulo, Brazil.
²⁸ Division of Translational Neurosciences and Population Studies, Medical University of South Carolina, Charleston, SC, USA.

PMID: 31769155
PMCID: PMC8030388
DOI: 10.1111/jch.13741

Erratum in

Erratum.
[No authors listed] [No authors listed] J Clin Hypertens (Greenwich). 2020 Feb;22(2):309. doi: 10.1111/jch.13821. J Clin Hypertens (Greenwich). 2020. PMID: 32091669 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

Conflict of interest statement

NRCC was a paid consultant to the Novartis Foundation (2016‐2017) to support their program to improve hypertension control in low‐ to middle‐income countries, which includes travel support for site visits and a contract to develop a survey. NRCC has provided paid consultative advice on accurate blood pressure assessment to Midway Corporation (2017) and is an unpaid member of World Action on Salt and Health (WASH). AES received speaker fees from Novartis and Omron for scientific lectures on blood pressure and risk assessment, and Servier for presenting on raising awareness of blood pressure measurement. She is a paid consultant to Abbott Pharmaceuticals on antihypertensive medication and is President of the International Society of Hypertension. MAW has served as a consultant to AbbVie and Bristol Myers Squibb on drug safety and has received travel funds from Omron. He is a member of advisory boards of Medtronic, ReCor, and Ablative Solutions. MO reports honoraria for talks from Glaxo Smith Kline (GSK) and Takeda Inc GP reports honoraria from Omron Health Care, Sanofi, and Servier. AR reports conference support by Servier. PW, LAB, PO, XHZ, CV, TK, DL, MJ, AM, FLP, MB, EB, and JS do not have any financial conflicts of interest to declare.

References

1. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population‐based studies from 90 countries. Circulation. 2016;134(6):441‐450. - PMC - PubMed
1. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle‐aged women and men. JAMA. 2002;287(8):1003‐1010. - PubMed
1. World Health Organization . A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. World Health Day 2013. Geneva, Switzerland: World Health Organization; 2013.
1. Muntner P, Carey RM, Gidding S, et al. Population impact of the 2017 American college of cardiology/American heart association high blood pressure guideline. J Am Coll Cardiol. 2018;71(2):109‐118. - PMC - PubMed
1. Wang JG, Liu L. Global Impact of 2017 American college of cardiology/American heart association hypertension guidelines: a perspective from China. Circulation. 2018;137(6):546‐548. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

São Paulo call to action for the prevention and control of high blood pressure: 2020

Affiliations

São Paulo call to action for the prevention and control of high blood pressure: 2020

Authors

Affiliations

Erratum in

Conflict of interest statement

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous